BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Thermo Fisher Introduces MagMAX™ HMW DNA Kit to Streamline Long-Read Sequencing Workflows

Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ HMW DNA Kit, providing a streamlined manual and automated extraction wo...

August 01, 2025 | News

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

July 31, 2025 | News

South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech

Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-developmen...

July 31, 2025 | News

Bristol Myers Squibb and Bain Capital Launch New Biotech Company with $300M to Advance Autoimmune Therapies

Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for...

July 29, 2025 | News

Bayer’s Elinzanetant Faces FDA Review Extension, No Concerns Raised on Approvals

Bayer announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinza...

July 28, 2025 | News

Sarepta Therapeutics Reaffirms Commitment to Patient Safety Following FDA Update on Unrelated Fatality

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, issued the following statement in response to an FDA...

July 28, 2025 | News

Eppendorf Launches BioBased Safe-Lock Tubes Made from 100% Renewable Materials

The new generation of Safe-Lock Tubes is finally also biobased. "Eppendorf Safe-Lock Tubes BioBased" are made from 100 % renewable biobased feedstock of se...

July 25, 2025 | News

Hillhurst Doses First Patient in Phase 2a Trial of Oral CO Therapy for Sickle Cell Disease

Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products bas...

July 24, 2025 | News

Global Call for Self-Care Integration as World Faces NCD Crisis

On International Self-Care Day, and as world leaders prepare for a landmark United Nations General Assembly meeting on non-communicable diseases (NCDs) thi...

July 24, 2025 | News

BD Launches First Pharma-Sponsored Clinical Trial Using Libertas™ Wearable Injector for Subcutaneous Biologic Delivery

The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pr...

July 24, 2025 | News

New England Biolabs Launches Low-Bias Small RNA Library Prep Kit to Advance RNA Sequencing Accuracy

New England Biolabs (NEB®) nnounced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimize biased representation of s...

July 23, 2025 | News

AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment

Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in th...

July 22, 2025 | News

FDA Pulls Emergency Brake on Sarepta's Gene Therapy Trials Amid Fatal Safety Crisis

The U.S. Food and Drug Administration announced it has placed Sarepta Therapeutics investigational gene therapy clinical trials for limb girdle muscular dy...

July 21, 2025 | Regulatory

Thermo Fisher to Acquire Sanofi’s Ridgefield Site, Expanding U.S. Steriles Manufacturing Capacity

Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additional ...

July 17, 2025 | News

Stay Connected